• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
Generic Name: betamethasone
Date Designated: 10/07/2015
Orphan Designation: Treatment of Ataxia Telangiectasia.
Orphan Designation Status: Designated
FDA Orphan Approval Status: Not FDA Approved for Orphan Indication
Acasti Pharma Inc.
3009 Boulevard De la Concorde E., Suite 102
Laval, Quebec H7E 2B5

The sponsor address listed is the last reported by the sponsor to OOPD.

*Exclusivity Protected Indications are shown for approvals from Jan. 1, 2013, to the present.